Recent research has shown that metformin reduces this exaggerated synaptic release and Munc18-1 accumulation in the presynaptic terminals of neurons in Fmr1 KO mice (Takeda et al., 2023) and suggests the value of research into the association between LRRTM2 and FXS. Here, LRRTM2 is linked to fragile X syndrome.